## **Core Concept**
Pulmonary fibrosis is a condition characterized by scarring of lung tissue, leading to respiratory symptoms. Certain medications are known to cause pulmonary fibrosis as a side effect. The question tests knowledge of drug-induced pulmonary fibrosis.

## **Why the Correct Answer is Right**
Bleomycin, a chemotherapeutic agent, is well-known for its potential to cause pulmonary fibrosis. It works by inducing DNA strand breaks, which leads to cell death, particularly in rapidly dividing cells. However, it can also cause fibrosis in lung tissue, leading to pulmonary fibrosis. This side effect is dose-dependent and can be severe enough to limit the use of bleomycin in cancer treatment.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Methotrexate is a chemotherapeutic agent and immune system modulator that can have pulmonary side effects, but it more commonly causes pneumonitis rather than pulmonary fibrosis directly.
* **Option B:** Cyclophosphamide is another chemotherapeutic agent that can have pulmonary side effects, including pneumonitis and pulmonary fibrosis, but it is less commonly associated with pulmonary fibrosis compared to bleomycin.
* **Option D:** Cisplatin is a chemotherapeutic agent used to treat various types of cancers. While it has several side effects, it is not commonly associated with pulmonary fibrosis directly.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that bleomycin-induced pulmonary fibrosis is a significant concern in oncology, particularly because it can be irreversible. Monitoring lung function tests is crucial in patients receiving bleomycin.

## **Correct Answer:** . Bleomycin